EcoDrugPlus

Glutaminase A

Ensembl ID : ENSTNIG00000017162
Gene Symbol: GLSA
2 Cross references
228 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSTNIG00000006988
Gene Symbol: GSK3AA
2 Cross references
187 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSTNIG00000003519
Gene Symbol: GSK3AB
2 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSTNIG00000013933
Gene Symbol: GSK3BA
2 Cross references
222 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor 1

Ensembl ID : ENSTNIG00000004999
Gene Symbol: GNRHR1
3 Cross references
135 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSTNIG00000006633
Gene Symbol: GHRHR
3 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor A

Ensembl ID : ENSTNIG00000006665
Gene Symbol: GHSRA
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSTNIG00000012359
Gene Symbol: GUCY1A1
2 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSTNIG00000019696
Gene Symbol: GUCY1A2
3 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSTNIG00000000147
Gene Symbol: GUCY1B1
2 Cross references
210 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class A Member 1, Tandem Duplicate 1

Ensembl ID : ENSTNIG00000010975
Gene Symbol: HSP90AA1.1
2 Cross references
330 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class B Member 1

Ensembl ID : ENSTNIG00000012221
Gene Symbol: HSP90AB1
2 Cross references
339 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).